Middle East Pharmaceutical Industries Company Sustainability Profile
Middle East Pharmaceutical Industries Company (MEPIC), headquartered in Saudi Arabia, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and branded medications. Established in the early 1990s, MEPIC has achieved significant milestones, including the expansion of its operational footprint across the Middle East and North Africa (MENA) region. MEPIC's core product offerings encompass a diverse range of therapeutic areas, including cardiovascular, anti-infective, and central nervous system medications. What sets MEPIC apart is its commitment to innovation and quality, ensuring that all products meet stringent international standards. With a strong market position, MEPIC has garnered recognition for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Middle East Pharmaceutical Industries Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Middle East Pharmaceutical Industries Company's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Middle East Pharmaceutical Industries Company's reported carbon emissions
Middle East Pharmaceutical Industries Company, headquartered in Saudi Arabia, currently does not report any carbon emissions data for the most recent year, nor does it have specific reduction targets or commitments outlined. The absence of emissions data suggests that the company may not have publicly disclosed its carbon footprint or climate initiatives at this time. As there are no specific climate pledges or targets from the Science Based Targets initiative (SBTi) or other recognised frameworks, it remains unclear how the company plans to address its environmental impact. Without available data or commitments, it is difficult to assess their position within the pharmaceutical industry's broader climate context. Overall, the lack of emissions reporting and climate commitments indicates a potential area for improvement in transparency and sustainability efforts within Middle East Pharmaceutical Industries Company.
How Carbon Intensive is Middle East Pharmaceutical Industries Company's Industry?
How Carbon Intensive is Middle East Pharmaceutical Industries Company's Location?
Middle East Pharmaceutical Industries Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Middle East Pharmaceutical Industries Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
